Status:

UNKNOWN

Spleen Stiffness as a Measure to Assess the REsponse to β Blocker Therapy (SPARE-B)

Lead Sponsor:

Institute of Liver and Biliary Sciences, India

Conditions:

High Risk Esophageal Varices

Eligibility:

All Genders

18-70 years

Brief Summary

HVPG is the gold standard for measurement of the presence and severity of portal hypertension. Clinically Significant Portal Hypertension (CSPH) is defined as HVPG ≥ 10 mmHg. Reducing the HVPG by use ...

Detailed Description

Aim and Objective: To evaluate change in splenic stiffness measurement as a surrogate for response to non-selective beta blockers in patients with high-risk esophageal varices. Primary objectives: To...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years
  • Cirrhosis of liver of different etiologies, with evidence of high-risk esophageal varices
  • Alcohol abstinence for 3 months
  • Written informed consent

Exclusion

  • Age ≥ 70 years
  • Previous or imminent variceal ligation
  • Non Cirrhotic Portal Hypertension
  • Portal vein, splenic vein thrombosis
  • Porto-systemic shunts \> 10 mm
  • Patients already on beta blockers
  • Contraindications to beta blocker therapy :
  • Heart rate \< 50 bpm
  • Systolic BP \< 100 mm Hg
  • Severe COPD
  • Atrioventricular block
  • Known PVD
  • Poor control of T2DM (HbA1c\>9)
  • Technical difficulties for splenic stiffness measurement
  • Cardio-pulmonary disorders
  • Budd Chiari Syndrome
  • Grade 3 ascites
  • Acute Kidney Injury or Chronic Kidney Disease
  • Severely Obese patients (BMI \> 40)
  • Pregnant women
  • Advanced HCC
  • Psychiatric Illness
  • Lack of informed consent

Key Trial Info

Start Date :

September 30 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 31 2024

Estimated Enrollment :

130 Patients enrolled

Trial Details

Trial ID

NCT06050837

Start Date

September 30 2023

End Date

August 31 2024

Last Update

September 22 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institute of Liver & Biliary Sciences

New Delhi, National Capital Territory of Delhi, India, 110070